It is currently Wed Apr 23, 2014 11:55 am

News News of Copaxone

Site map of Copaxone » Forum : Copaxone

A board to discuss the Multiple Sclerosis modifying drug Copaxone

Copaxone Injection Sites

My doctor has prescribed Copaxone, but I am reluctant to give it a try. I read that the injection sites often are left with pits and/or knots in the skin. Does anyone know if this is due to the auto-inject system or a side effect of the medicine itself?

Thanks!!

Robin
Read more : Copaxone Injection Sites | Views : 3747 | Replies : 3


Copaxone Reaction

Just wanted to quickly document my first bad reaction to copaxone after being on it 5 months.

I injected it as usual (although this time I did bleed quite badly afterwards which makes me think I might have injected into a blood vessel)

After about 3 minutes I had a feeling of very very mild breathing issues and a slight feeling of flushing (this was all so minimal that although I knew it was a ...
Read more : Copaxone Reaction | Views : 1871 | Replies : 0


How long does it take for Copaxone to become effective?

I was wondering if anyone new knew long it takes for Copaxone to reach a clinical level in your body and begin to slow the progression of MS? I went off of Rebif about 6 months ago due to the side effects. I feel 10x better off of the Rebif; however, when I told my neurologist I ended the Rebif and wanted to take Copaxone he discouraged me and said that Copaxone is not as ...
Read more : How long does it take for Copaxone to become effective? | Views : 4795 | Replies : 6


Higher patient adherence to DMDs reduces MS costs

Image

Avi Dor, Ph.D., professor in the Department of Health Policy, GW School of Public Health and Health Services, was a co-author of a study, in collaboration with Teva Pharmaceuticals, that found that higher patient adherence to disease modifying therapies, like glatiramer acetate (GA), an immunomodulator drug currently used to treat multiple sclerosis, reduced inpatient costs, outpatient costs, and other medical expenses in a national sample of multiple sclerosis patients.

This research was published in ...
Read more : Higher patient adherence to DMDs reduces MS costs | Views : 1644 | Replies : 0


Weight Gain

I was diagnosed with MS in February of this year. Since then I have started copaxone in early March. By June put almost 5-6 pounds. and now I am up a good 10-15. I have tried weight watchers and I am now on south beach but i just keep putting it on. I know a lot of this is likely comfort eating, but I shouldn't still be gaining while on such a severe diet like ...
Read more : Weight Gain | Views : 1891 | Replies : 4


Missed an injection day

Hello,

My name is Peter, I am 29 years old. I have been diagnosed with MS less than 2 months ago. My first and only relapse so far has been a case of optic nuritis. I have been taking Copax. for about 3 weeks.

no major problems with it but last night I missed an injection because I fell asleep after work. Totally a bad move on my part. I have about 2 hours before ...
Read more : Missed an injection day | Views : 2611 | Replies : 4


Synthon’s Glatiramer Acetate (GTR) in RRMS

Has anyone heard about this:
Synthon’s Glatiramer Acetate (GTR) in RRMS?
What is the difference comparing it to well known glatiramer acetate?
Read more : Synthon’s Glatiramer Acetate (GTR) in RRMS | Views : 1429 | Replies : 0


Glatiramer acetate better than Interferon for MS fatigue

Image


Glatiramer acetate (GA) reduces fatigue in multiple sclerosis patients more than interferon beta-1b (IFN-1b) after 1 year of treatment, according to a new study.

IFN-1b had no impact on two clinical measures of fatigue, while GA (Copaxone) reduced the score on the Fatigue Severity Scale (FSS) by 20%, and the score on the Fatigue Descriptive Scale (FDS) by 34%, according to a study presented here at the European Committee for Treatment and Research in ...
Read more : Glatiramer acetate better than Interferon for MS fatigue | Views : 1976 | Replies : 0


Copaxone demonstrates remyelination & neuroprotective effect

Image

Teva Pharmaceutical Industries Ltd. today announced preclinical data demonstrating reparative and neuroprotective effects of treatment with Copaxone(R) (glatiramer acetate injection) in experimental autoimmune encephalomyelitis (EAE) models. In the study, researchers compared mice treated with Copaxone(R) versus non-treated mice in relapsing-remitting and chronic multiple sclerosis (MS) disease models. Researchers observed both remyelination indicative of repair and a drastic reduction of demyelination and axonal loss in mice treated with Copaxone(R).... Read More - ...
Read more : Copaxone demonstrates remyelination & neuroprotective effect | Views : 1718 | Replies : 0


Significant reduced loss of brain volume in MS patients

Significant reduced loss of brain volume in MS patients treated with Copaxone

Image

Results from a five-year study of treatment-naïve patients with relapsing-remitting multiple sclerosis (RRMS) demonstrated that patients treated with Copaxone (glatiramer acetate injection) showed significant reduced loss of brain volume compared to patients treated with other disease modifying therapies (DMTs).

Though all DMT treatment arms resulted in a reduction in brain volume loss compared to the control group of non-treated patients, Copaxone had ...
Read more : Significant reduced loss of brain volume in MS patients | Views : 1014 | Replies : 1


 

Login  •  Register


Statistics

Total posts 216599 • Total topics 22130 • Total members 13918

cron